Organon (OGN) Change in Cash (2021 - 2026)
Organon (OGN) posted quarterly Change in Cash of $16.0 million for Q2 2026, down 69.23% year-over-year from $52.0 million in Q2 2025, and down 97.05% on a QoQ basis from $542.0 million in Q1 2026.
Organon (OGN) Change in Cash (2021 - 2026) Analysis & Trends
Organon has reported Change in Cash for 6 years, with the latest figure at $16.0 million in Q2 2026.
- Change in Cash for Q2 2026 came in at $16.0 million, down 69.23% year-over-year; the trailing twelve-month figure through Jun 2026 was $533.0 million (up 607.62% YoY), and the FY2025 annual result was -$101.0 million, down 461.11% from the prior year.
- Change in Cash fell to $16.0 million in Q2 2026, from $542.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $542.0 million in Q1 2026 and troughed at -$247.0 million in Q1 2023.
- A 5-year average of $21.9 million and a median of -$13.5 million in 2022 frame the typical range for Change in Cash.
- The widest annual swing landed in 2023, when Change in Cash slumped 474.42%; it then soared 523.44% in 2026.
- A 5-year view of Change in Cash shows it stood at $207.0 million in 2022, then surged by 34.78% to $279.0 million in 2023, then plunged by 131.54% to -$88.0 million in 2024, then slipped by 11.36% to -$98.0 million in 2025, then jumped by 116.33% to $16.0 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were $16.0 million in Q2 2026, $542.0 million in Q1 2026, and -$98.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.49 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 739.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -4.45 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -727.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 16.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.00 Mn |
| Mar 31, 2026 | 542.00 Mn |
| Dec 31, 2025 | -98.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 52.00 Mn |
| Mar 31, 2025 | -128.00 Mn |
| Dec 31, 2024 | -88.00 Mn |
| Sep 30, 2024 | 59.00 Mn |
| Jun 30, 2024 | 129.00 Mn |
| Mar 31, 2024 | -118.00 Mn |
| Dec 31, 2023 | 279.00 Mn |
| Sep 30, 2023 | 88.00 Mn |
| Jun 30, 2023 | -133.00 Mn |
| Mar 31, 2023 | -247.00 Mn |
| Dec 31, 2022 | 207.00 Mn |
| Sep 30, 2022 | -46.00 Mn |
| Jun 30, 2022 | -149.00 Mn |
| Mar 31, 2022 | -43.00 Mn |
| Dec 31, 2021 | -271.00 Mn |
| Sep 30, 2021 | 278.00 Mn |